By using an enzyme-linked immunosorbent assay, serum immunoglobulin A (IgA) responses directed against Strongyloides stercoralis larvae antigens were measured in 104 presumably immunocompetent individuals with chronic uncomplicated strongyloidiasis and in 15 immunocompromised patients with S. stercoralis infection. Fifty healthy North American adults and 18 patients with other helminthic parasites served as controls. All 50 healthy controls were negative for antibody responses (mean absorbance standard deviation = 0.0724 0.040). The mean absorbance of the 18 parasitized controls was 0.230 ± 0.087; two individuals parasitized by Ascaris lumbricoides showed positive antibody responses. The mean absorbance of the immunocompetent patients with strongyloidiasis was 0.680 ± 0.364, with 91 subjects (87.5%) having a positive value (>0.300). Of the immunocompromised patients (mean absorbance ± standard deviation = 0.735 ± 0.538), 11 (73%) had a positive antibody response test. When the IgA responses of these two groups were compared, they were not significantly different. There was no correlation between the levels of total serum IgA and the concentration of specific IgA in the infected patients. Both IgA and IgG immunoreactive bands were detected on immunoblots of sodium dodecyl sulfate-polyacrylaniide gel electrophoresis-separated larval antigen protein blots. Nineteen bands were recognized by IgG, and 13 were recognized by IgA from sera of infected patients. Several bands displayed specific IgG or IgA reactivity. The present work shows that most patients with strongyloidiasis mount specific IgA responses against filariform larval antigens. These responses are, for the most part, directed against antigens that are different from those recognized by IgG. The lack of correlation between the magnitude of the specific serum IgA responses and the clinical aspects of the infection suggests that these antibodies may not play a central role in the regulation of this parasitosis.
The increasing use of immunosuppressive drugs and cytotoxic regimens and the present pandemic of the acquired immunodeficiency syndrome are changing the clinical and epidemiological features of certain parasitic diseases. The concept of "opportunistic parasite" is now accepted, its foremost representative being Pneumocystis carinii, now the leading cause of death in patients with acquired immunodeficiency syndrome (28) .
Strongyloides stercoralis, because of its unique ability to replicate within its host, is the only nematode capable of opportunistic behavior (5, 13) . This insidious parasite, which may persist indefinitely as a silent guest in its human host (20) , is now one of the most commonly diagnosed helminthic parasites in the United States, both in rural (29) and in urban (27) areas. In Europe, where hundreds of imported, as well as autochthonous, cases have been reported, endemic foci have been identified in several countries (4, 23) .
As fatal disseminated strongyloidiasis begins to make its appearance in acquired immunodeficiency syndrome patients (21; M. Wittner and H. B. Tanowitz, personal communication), the need for a better understanding of the relationship between host and parasite is becoming more pressing.
In an effort to clarify the immunological aspects of this relationship and to provide better tools for the diagnosis of this elusive nematode, we have previously studied the parasite-specific cellular responses in individuals with uncomplicated strongyloidiasis (9) and the immunoglobulin G (IgG) (11) and IgE (19) responses in patients with chronic, uncomplicated strongyloidiasis and in a small group of immunocompromised patients with or without dissemination (7) .
Because of its intestinal localization and its continuous recycling through the lungs, S. stercoralis is likely to elicit local and systemic IgA responses. To our knowledge, however, no attempt had been made to measure or characterize these responses. In the present study, we focused on the characterization of serum IgA against larval antigens in a large number of patients with different forms of strongyloidiasis. These data were used to explore the relationship between the magnitude of these responses, the presence of other classes of parasite-specific antibodies, and the clinical course of the infection. (ii) ELISA. IgA directed against S. stercoralis larval antigens was measured by using an enzyme-linked immunosorbent assay (ELISA) adapted from a method previously described for the measurement of parasite-specific IgG (6) . Briefly, alternating rows of flat-bottom microtiter plates (Dynatech Laboratories, Inc., Alexandria, Va.) were sensitized with S. stercoralis larval antigen at a concentration of 5 ,ug/ml of PBS. Each serum was tested at the single dilution of 1:8 both in a well with antigen and in a well without antigen. This dilution was selected because, in preliminary experiments, it provided the best discrimination between infected patients and controls. The test was then completed by using goat anti-human IgA conjugated with alkaline phosphatase (Kirkegaard and Perry Laboratories, Gaithersburg, Md.) at a dilution of 1:1,000 (determined to be optimal by block titration). The specificity of this conjugated antiserum was confirmed by immunodiffusion and by the ELISA. (vi) Determination of parasite-specific IgG and IgE. The levels of Strongyloides-specific IgG were measured in all patients by the ELISA, as previously described (7) . Results are expressed as the net absorption, a figure correlated with the amount of antibody present in the serum. Specific-IgE levels were measured by a previously described solid-phase radioallergosorbent assay (19 Specific IgA values were significantly different in the three geographic subgroups of immunocompetent patients (Table  2 ). Both Latin Americans and Southeast Asians had significantly higher specific IgA values than a group of infected patients who either were North Americans or had been residents of the United States for at least 3 years (P < 0.001 by the analysis of variance). However, no difference was detectable when Latin Americans and Southeast Asians were compared with each other.
MATERIALS AND METHODS
Positivity. The mean absorbance value of all 68 controls (50 nonparasitized and 18 with other parasites) was 0.114, with an SD of 0.09. This mean plus 2 SD (0.294) was used as the upper negative limit. Thus, an absorbance value of 0.300 or higher was considered positive.
Specificity studies. Preabsorption with S. stercoralis soluble antigens of sera from patients with strongyloidiasis resulted in an average 82% decrease in the absorbance value. Six of these sera were preabsorbed with live filariform and rhabditiform larvae; the average decrease in the absorbance value was 21%. Preabsorption of the same sera with Ascaris suum antigens did not significantly alter the absorbance values. When the sera of two individuals with A. lumbricoides infections were preabsorbed with A. suum antigens, no significant variation of the absorbance value occurred. Because Asc-1 is an affinity-purified preparation and does not contain all Ascaris antigens, these results can only be interpreted as indicating that Asc-1 antigens are not major components of S. stercoralis.
Specific IgG and IgE. The results of specific IgG and IgE tests are summarized in Table 3 specific IgG and IgE responses were compared by the one-way analysis of variance.
A weak correlation existed between the levels of specific IgG and specific IgA in the infected patients (r2 = 0.2304); no correlation existed between the levels of specific IgA and specific IgE (r2 = 0.0121).
Total IgA. The levels of total IgA were measured in all patients with strongyloidiasis, in the parasitized controls, and in randomly selected nonparasitized controls. The IgA levels of the immunocompetent patients ranged from 7 to 1,326 g/dl (mean ± SD = 227 ± 190). These values did not differ from standard normal values obtained in our laboratory (222 ± 129 g/dl). The immunocompromised patients had total IgA levels between 9 and 334 g/dl (mean + SD = 121 ± 99 g/dl). This value was significantly lower than that obtained in healthy persons and that of the immunocompetent patients (P < 0.05). The parasitized controls had values within the normal range (from 87 to 345 g/dl; mean ± SD = 205 + 143). The total IgA levels of 23 apparently immunocompetent U.S. residents were significantly lower than those of all of the other groups (125 ± 85 g/dl; P < 0.05), with the exception of the immunocompromised patients. The mean concentration of total IgA in a group of 18 randomly selected healthy controls was within normal limits (235 + 149 g/ml).
There was no correlation between the levels of total IgA and the concentration of specific IgA in the infected patients (r2 = 0.1444).
Immunoblotting studies. IgA and IgG immunoreactive bands were detected on immunoblots of SDS-polyacrylamide gel electrophoresis-separated larval antigen protein blots. Nineteen distinct bands were recognized by IgG, and 13 distinct bands were recognized by IgA from the sera of infected patients (Fig. 2) . Five (Fig. 2) . Another band with an apparent molecular weight of 46,400 ( (14) . The participation of mucosal IgA in the intestinal expulsion of experimental murine Nippostrongylus brasiliensis infections has been extensively investigated (17, 25, 30) , and the modulation of these responses by mucosal T-cells has been partially elucidated (18) . In contrast to the growing volume of experimental work with animal models, the function of IgA in human parasitic infections has received little attention. Yet it is likely that local defenses play a critical role in host resistance against intestinal helminths (1, 2) .
S. stercoralis, with its long permanence in the host's intestine and the continuous recycling of the filariform larvae, subjects the host to a constant exposure to parasite antigens. The (12) . However, the biological role of secretory IgA as a first line of defense at the mucosal surface is receiving wide acceptance (3) , and an effort to explore this problem in a canine model of strongyloidiasis is under way in our laboratory.
Whereas the immunocompromised patients in this study had significantly lower total IgA levels than infected persons with an apparently intact immune system, there was no correlation between the titers of parasite-specific serum IgA and the clinical form of strongyloidiasis. Furthermore, absence of detectable circulating specific IgA was not necessarily associated with immunosuppression or dissemination. This may suggest that these antibodies, directed against filariform larval antigens, do not play a central role in the regulation of the infection. A similar situation appears to exist in the case of anti-filariform larva IgG in both humans (7) and animal models (8, 10) . Conversely, we previously reported an association between lower levels of parasitespecific IgE and immunosuppression, with or without dissemination (7). The present study, which included eight additional immunocompromised patients, confirmed our previous findings, suggesting that the possible protective role of IgE in strongyloidiasis may deserve further attention. The lower levels of both total and specific IgA found in infected U.S. residents are not easily explained. It is possible that the infections in these individuals were more chronic than in the two groups from endemic areas, who could be exposed to the parasite constantly. Also, although most 
